AI assistant
JUNO MINERALS LIMITED — Director's Dealing 2025
Dec 1, 2025
65164_rns_2025-12-01_8c953d6a-2b4a-403b-ba81-ec1e96ba8853.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name | of entity | Juno Minerals Limited |
|---|---|---|
| ABN | 94 645 | 778 892 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Greg Durack |
|---|---|
| Date of last notice | 7 December 2023 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Direct - Mr Gregory Michael Durack Indirect - Mr Gregory Michael Durack & Mrs Kimberley Ann Durack Ekoyenia S/F A/C> |
| Date of change | 2 December 2025 |
| No. of securities held prior to change | Mr Gregory Michael Durack - 800,000 shares Mr Gregory Michael Durack & Mrs Kimberley Ann Durack S/F A/C> - 766,667 shares |
| Class | Performance rights (Subject to vesting conditions) |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | 3,000,000 |
|---|---|
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Nil cash conditions, deemed valuation as follows: 1,000,000 - $0.0237 per performance right 1,000,000 - $0.0211 per performance right 1,000,000 - $0.013 per performance right |
| No. of securities held after change | Mr Gregory Michael Durack - 800,000 shares - 3,000,000 performance rights (expiring 2 December 2028 - subject to vesting conditions) Mr Gregory Michael Durack & Mrs Kimberley Ann Durack S/F A/C> - 766,667 shares |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
Issue of performance rights (subject to vesting conditions) as approved by shareholders at the AGM held 26/11/2025 (refer to resolution 6). |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
|---|---|
| Interest after change | N/A |
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
2 December 2025
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3